乳腺癌保乳手术联合术中放疗适应证研究进展
王子祥 吴爱国[摘要] 乳腺癌是居全球女性发病率前列的恶性肿瘤之一,临床常用的全乳腺切除的手术方式,对患者的心理和美容造成很大影响。保乳手术(BCS)联合术中放射治疗(IORT),由于减少了放射治疗周期和周围正常组织放射剂量,同时又保持了良好的肿瘤治疗特异性和较好的美容效果,因此保乳手术联合术中放疗得到了国际上的支持。但是,在IORT患者的选择方面,存在多个意见,但是并未达成共识,甚至其中一些提出了相互矛盾的观点。笔者就乳腺癌保乳手术联合术中放疗适应证相关研究进行综述。以便为临床医生的医疗决策提供借鉴和参考。
[关键词] 乳腺癌;保乳手术;术中放疗;局部复发
[中图分类号] R737.9 [文献标识码] A [文章编号] 1673-7210(2018)05(c)-0038-05
Progress of breast-conserving surgery combine intraoperative radiotherapy indication for breast cancer
WANG Zixiang WU Aiguo▲
General Surgery, Zhujiang Hospital of Southern Medical University, Guangdong Province, Guangzhou 510282, China
[Abstract] Breast cancer is the most common disease in women worldwide, the whole-mammectomy surgery greatly effects on the patients′ psychological and beauty. Breast-conserving surgery (BCS) combined intraoperative radiotherapy (IORT) gained international favor because of its reduction in treatment duration, decreased irradiation of healthy organs, and maintain favorable cancer-specific and better cosmetic outcomes. However, in terms of selecting patients, multiple opinions existed ......
您现在查看是摘要页,全文长 17804 字符。